Epidemiology and risk factors of lower urinary tract symptoms/benign prostatic hyperplasia and erectile dysfunction.


Journal

The aging male : the official journal of the International Society for the Study of the Aging Male
ISSN: 1473-0790
Titre abrégé: Aging Male
Pays: England
ID NLM: 9808210

Informations de publication

Date de publication:
Mar 2019
Historique:
pubmed: 3 2 2018
medline: 2 5 2019
entrez: 3 2 2018
Statut: ppublish

Résumé

Benign prostatic hyperplasia (BPH) is very common in aging men and causes lower urinary tract symptoms (LUTS), which decrease health-related quality of life. A number of evidence suggests that other than ageing, modifiable factors, such as increasing prostate volume, obesity, diet, dyslipidemia, hormonal imbalance, hypertension, metabolic syndrome, alcohol, and smoking, also contribute to the development of BPH and/or LUTS. More recently, erectile dysfunction (ED) has been linked to LUTS/BPH as a part of this syndrome, suggesting that patients with BPH or LUTS easily develop ED, and that LUTS/BPH symptoms often coexist with ED. This article focuses on the epidemiology and risk factors of the combined phenotype LUTS/BPH - ED.

Identifiants

pubmed: 29392976
doi: 10.1080/13685538.2018.1434772
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

12-19

Auteurs

Aldo E Calogero (AE)

a Department of Clinical and Experimental Medicine , University of Catania , Catania , Italy.

Giovanni Burgio (G)

a Department of Clinical and Experimental Medicine , University of Catania , Catania , Italy.

Rosita A Condorelli (RA)

a Department of Clinical and Experimental Medicine , University of Catania , Catania , Italy.

Rossella Cannarella (R)

a Department of Clinical and Experimental Medicine , University of Catania , Catania , Italy.

Sandro La Vignera (S)

a Department of Clinical and Experimental Medicine , University of Catania , Catania , Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH